Alejandro Sousa - Publications

Analysis of the Tolerance and Safety of the Rezum System for the Treatment of Benign Prostatic Hyperplasia.

Journal: Archivos espanoles de urologia

Published: October 20, 2025

Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.

Journal: European urology oncology

Published: May 18, 2022

Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.

Journal: Frontiers in surgery

Published: September 14, 2021

Anuria secondary to impacted stones in both ureteral meatus.

Journal: Archivos espanoles de urologia

Published: June 03, 2021

Should we discount the laboratory origin of COVID-19?

Journal: Environmental chemistry letters

Published: March 31, 2021

Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: February 27, 2016

Analysis of budgetary impact of moderate and high risk non muscle-invasive bladder cancer by means of neoadjuvant hyperthermia chemotherapy compared to the standard adjuvant treatment with BCG

Journal: Archivos espanoles de urologia

Published: June 24, 2015

A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: April 05, 2014